KKR Buys Minority Stake in Malaysia's Avisena Healthcare
By Megan Cheah
KKR is picking up a minority stake in Malaysia's Avisena Healthcare, as the investment firm seeks to accelerate the healthcare provider's growth strategy.
The New York-based firm said Friday that the investment, made through its-managed funds, will bolster offerings at Avisena's flagship hospitals in Shah Alam, Malaysia, and building of greenfield hospitals within the country's Klang Valley.
KKR didn't disclose the financial terms of the deal. Founded in 1996, Avisena operates two private hospitals in Malaysia.
The country's private healthcare market "is experiencing growing demand, with capacity growth lagging demand in key urban areas," KKR said.
Deal activity in Asia's medical-services sector has been robust recently, spurred by growing patient volumes and healthcare spending. An expanding middle class and urbanization are creating investment opportunities within the region's burgeoning hospital and specialty-care assets.
KKR has invested more than $20 billion into the global healthcare industry since 2004. Its Asia-Pacific portfolio includes investments in Vietnam's Medical Saigon Group and the Philippines' Metro Pacific Hospital Holdings.
Write to Megan Cheah at megan.cheah@wsj.com
(END) Dow Jones Newswires
September 03, 2026 21:56 ET (01:56 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States